Old Web
English
Sign In
Acemap
>
Paper
>
O13-3 Tepotinib in patients with MET exon 14 (METex14) skipping advanced NSCLC: Updated efficacy results from VISION cohort A
O13-3 Tepotinib in patients with MET exon 14 (METex14) skipping advanced NSCLC: Updated efficacy results from VISION cohort A
2021
Hiroshi Sakai
Masahiro Morise
Enriqueta Felip
Remi Veillon
Marina Chiara Garassino
Jo Raskin
Santiago Viteri
Julien Mazieres
Alexis B. Cortot
Egbert F. Smit
Michael Thomas
Byoung Chul Cho
Pierfranco Conte
James Chih-Hsin Yang
Yuh-Min Chen
Keunchil Park
Maya Gottfried
Christian Britschgi
Xiuning Le
Paul K. Paik
Keywords:
Internal medicine
Cohort
Oncology
in patient
Medicine
Exon
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]